How to Build a Pharma Supply Chain That Actually Scales

Most pharma and biotech companies build their supply chains reactively. They grow, they hit problems, they hire consultants, they fix issues, and then they repeat the cycle. There's a better way, and I want to share it with you.

I've spent the last eight years working inside the supply chain operations of pharma and biotech companies, and I've noticed something clear: The companies that scale smoothly aren't the ones with the best forecasting software or the biggest budgets. They're the ones that figured out how to make decisions together.

Let me explain what I mean, because it's simpler than you'd think, but it requires discipline.

The Scaling Challenge Nobody Talks About

When your biotech company is small maybe 15-20 people, $5-10 million revenue—you can operate mostly ad-hoc. The founder knows what's happening. Decisions get made fast. People wear multiple hats. Communication happens over coffee.

It works. Until it doesn't.

Usually around $20-30 million revenue, things start breaking. You hire more people. You add process. You implement systems. But somehow, decisions get slower, not faster. Information gets lost between departments. People aren't sure who decides what.

The supply chain starts creating problems instead of solving them.

Most companies respond by hiring more people ("We need a VP of Operations") or buying better software ("We need a modern ERP system"). Sometimes both.

But here's what I've observed: Adding people and buying software doesn't fix the underlying problem.

The underlying problem is governance.

What Governance Actually Means (And Why It's Not What You Think)

When I say "governance," most people think I mean policies. Like, "here's our governance document that explains how we make decisions."

That's not governance. That's documentation. Documentation is useful. But documentation doesn't create real change.

Real governance is: How decisions actually get made. By whom. With what information. And what happens when things don't go according to plan.

Here's the difference between struggling and scaling companies:

Struggling companies:

• Planning happens monthly (or ad-hoc)
• Different departments use different data
• Decision authority is unclear
• When something breaks, it becomes a crisis
• Leaders spend their time firefighting
• Change management is chaotic

Scaling companies:

• Planning happens weekly
• All departments use the same data
• Decision authority is crystal clear
• When something breaks, it's addressed in context
• Leaders spend their time strategizing
• Change happens in structured ways

The difference isn't the people. It's the process.

I worked with a biotech company that was at $40 million revenue and falling apart under its own growth. Constantly late shipments. Inventory problems. Manufacturing bottlenecks. Frustrated leadership.

Then they implemented one thing: A weekly planning meeting.

Every week, same time, same place. Sales director brings demand data. Operations director brings manufacturing status. Supply chain director brings inventory position. Finance brings working capital impact. All in one room. 1 hour. Same people, every week.

Within three months, the firefighting stopped. Decisions got faster. Execution got smoother.

That's governance

The Three Areas That Break When You're Scaling

I've identified three specific areas where supply chains break as companies grow, if governance isn't in place.

1. Demand Planning Becomes a Guess Game

When you're small, you know your customers. You can feel the market. As you grow, you lose that intuition. You hire a demand planning person. They build models. Forecasts get more sophisticated.

But they're still guesses.

Real scenario: A biotech company forecasts 500 units per month for a new product launch. Forecast is based on market analysis, competitive intel, customer surveys. Reasonable forecast. Everyone believes it.

Actual uptake: 250 units per month.

Now you have a problem: You've built supply chain around 500 units. Manufacturing is sized for 500. CDMO capacity is reserved for 500. Inventory policy assumes 500.

But you only need 250.

Result: Excess inventory. Working capital tied up. Product expiring. Simultaneously, in markets where adoption is higher than expected, you have shortages.

How to prevent this: Weekly demand signal review. Not monthly. Weekly.

Every week, sales team brings actual data: orders, pipeline, point-of-sale if available. You compare to forecast. You see the trend. If actual is 15% below forecast, you start adjusting forward plans. If 20% below, you escalate to leadership. But you see it in week 2, not week 8.

This is governance. A structured decision-making rhythm based on real data.

2. Manufacturing Becomes Inflexible

Most companies commit to manufacturing partners (CDMOs) on fixed volumes 6-12 months in advance. "We need 500 units per month for the next year."

CDMO agrees. Contract signed. But six months later, market signals suggest you actually need 300 units per month.

You're now locked in. Either you pay for unused capacity (contractual obligation), or you take excess inventory (cash flow nightmare). Usually both.

I've seen companies waste $500K-$1M+ because they locked in capacity on forecasts that turned out wrong.

How to prevent this: Flexible capacity arrangements. "We need core capacity of 300 units per month, with flexibility to 600 if market demand justifies it. We'll review quarterly and adjust based on actual market signals."

This requires negotiation. CDMO benefits from knowing you have upside potential while taking on minimum commitment. You benefit from flexibility without penalty.

Again, this is governance. A structured relationship with clear decision points.

3. Cross-Functional Coordination Falls Apart

When you're small, departments coordinate naturally. Sales talks to operations. Operations talks to finance.

When you scale, departments start operating independently. Sales is focused on revenue. Operations is focused on efficiency. Finance is focused on cost control. They have different metrics, different incentives.

Result: Decisions conflict. One department optimizes locally and creates problems for another.

Real scenario: Sales commits to aggressive Q3 forecast (looking good for commission). Manufacturing locked in Q2 capacity because they didn't know Q3 would spike. Finance didn't account for inventory build. By September, you have simultaneous shortage + excess inventory in different product lines.

How to prevent this: Monthly S&OP meeting (Sales & Operations Planning).

All departments come together. They see demand from sales perspective. Manufacturing constraints from operations perspective. Working capital impact from finance perspective. Capacity potential from CDMO perspective.

They align on one plan. Not sales plan + operations plan + finance plan. One integrated plan.

What Successful Scaling Companies Actually Do

The companies I've worked with that scale smoothly implement five core practices:

Practice #1: Weekly Demand Signal Review

Every week, commercial team brings sales data. Supply chain brings inventory position. Operations brings manufacturing status. Finance brings working capital impact. You review plan vs actual. You adjust forward plans if needed.

This is where you catch demand surprises early. Week 2, not week 8.

Practice #2: Monthly S&OP (Sales & Operations Planning)

All functions in one room. One integrated forecast. One manufacturing plan. One inventory policy. One financial projection.

Not consensus aligned decision-making with clear authority.

Practice #3: Clear Decision Authority

When things break (and they will), everyone knows who decides. Not weeks of committee meetings. Clear escalation protocols.

If demand misses forecast by 10%: Routine adjustment, team lead decides.

If demand misses by 20%: Operations VP decides.

If demand misses by 30%: Executive decides.

Decisions made same day. No surprises.

Practice #4: Formalized CDMO Relationships

Not just contracts. Governance relationships.

• Clear capacity commitment (core + flex)
• Weekly production visibility
• Monthly capacity review
• Performance metrics
• Escalation protocols

When issues arise, they're addressed in context, not as fires.

Practice #5: Inventory Policy Tied to Reality

Inventory buffer tied to actual forecast accuracy and lead time. Not static guesses.

When forecast accuracy is 60%: Carry 3 months buffer

When forecast accuracy is 80%: Carry 1.5 months buffer

When forecast accuracy is 92%: Carry 1 month buffer

As you learn the market and forecasting improves, inventory decreases. Working capital improves. Cash flow improves.

The Real Impact

Companies that implement this framework consistently report:

• 85%+ forecast accuracy (vs 65% baseline)
• 95%+ on-time delivery (vs 60% baseline)
• 40% reduction in excess inventory
• $1-2M+ working capital freed up
• Decisions 3x faster (days vs weeks)
• Launch on-time rate: 95%+ (vs 60% typical)

It's not magic. It's discipline.

Why This Matters for Your Company

If you're a growing biotech or pharma company, you're at an inflection point. You can keep operating the way you have been, which got you to $20-40 million. But that approach will break as you scale further.

Or you can invest in governance structured planning, clear decision-making, integrated functions—that lets you scale to $100+ million without constantly being in firefighting mode.

The investment is small: Weekly meetings. Clear decision authority. Real-time data. Monthly adjustments.

The payoff is huge: Predictable growth. Healthy cash flow. Happy teams. Launches that feel planned, not chaotic.

Most companies realize they need this when they're already broken. They bring in consultants, implement changes reactively, add cost.

If you build it proactively, it costs you less and delivers more value.

The companies that figure this out early scale smoothly. The companies that wait until things break? They scale chaotically.

Start This Week

If you're managing a growing pharma or biotech supply chain, here's your action list:

Week 1:

• Map your current decision-making process (how are decisions really made?)
• Identify pain points (where does coordination break down?)
• Schedule weekly demand signal review (same time, same people, every week)

Week 2:

• Run first weekly meeting (bring actual sales data, inventory position, manufacturing status, finance impact)
• Discuss: What surprised you? What should we adjust?

Week 3:

• Implement findings from first week
• Begin planning first monthly S&OP (all functions)

Week 4:

• Run first S&OP
• Review quarterly demand/capacity alignment

Ongoing:

• Weekly meetings: Sacred. Don't cancel. Same people, same time.
• Monthly S&OP: Integrated planning for all functions
• Clear decision authority: Everyone knows who decides what
• Measure weekly: Forecast accuracy, on-time delivery, working capital impact

That's it. That's the framework.

The companies that execute this consistently scale without chaos. The companies that don't? They stay reactive, forever.

The choice is yours. And the time to choose is now before you hit the scale where reactive becomes impossible.